8-K current report · filed Aug 10, 2026

ACCENDRA HEALTH INC/VA/ (ACH) 8-K Current Report: August 10, 2026

Item 5.02Item EX-99.1Item 7.01ACH overview

Short answer

ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). CEO and director Edward A. Pesicka plans retirement by year-end 2026 or earlier successor appointment.

ACCENDRA HEALTH INC/VA/ 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • CEO and director Edward A. Pesicka plans retirement by year-end 2026 or earlier successor appointment
  • Board succession search underway, creating leadership-transition uncertainty
  • Departure unrelated to disagreements over operations, policies, or practices

Item 7.01 · Regulation FD Disclosure

  • CEO Mr. Pesicka announced intent to retire, creating leadership-transition uncertainty
  • Exhibit 99.1 contains the company’s press release and likely succession details
  • Investor focus: timing of departure, successor selection and continuity of strategy

Item EX-99.1 · Exhibit EX-99.1

  • CEO Edward A. Pesicka plans retirement by year-end 2026 after more than seven years
  • Board succession search underway, with previously identified candidates supporting transition planning
  • Pesicka will also leave the Board and may remain as an advisor beyond retirement
  • Leadership change follows divestiture of Owens & Minor, balance-sheet optimization, and management restructuring
  • CEO transition creates execution and strategic-continuity risk despite planned succession process

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ACCENDRA HEALTH INC/VA/ 8-K filings

Get the next ACH 8-K as it lands

Follow ACH for push alerts, or ask the research agent what this filing means.